Coca-Cola and Abbott Laboratories have increased dividends for a combined 116 consecutive years, showcasing their stability and reliability. Coca-Cola’s diversified portfolio and constant new launches contribute to its resilient business. Abbott Laboratories’ strong financial results and growth opportunities make it an attractive stock. President Trump’s trade policies create volatility in the stock market, impacting corporations’ financial results. Investing in Dividend Kings, like Coca-Cola and Abbott Laboratories, can navigate these challenges. Coca-Cola’s innovative approach and consistent revenue generation, along with Abbott Laboratories’ strong financial performance, bolster their positions as solid investments. Abbott Laboratories’ FreeStyle Libre franchise and diversified business in pharmaceuticals, diagnostic devices, and nutrition underscore its growth prospects. Coca-Cola’s manufacturing strategy insulates it from tariffs, and its 63-year dividend track record makes it a reliable choice. Abbott Laboratories’ 53-year dividend history and competitive edge make it a promising income stock.

Read more at Yahoo Finance: Don’t Overlook These 2 Dividend Kings in Today’s Volatile Market